Why Evolution (OM:EVO) Is Down 5.7% After Posting Rare Year-Over-Year Decline in Q3 Results

  • On October 23, 2025, Evolution AB released its third quarter results, reporting revenue of €507.12 million and net income of €252.33 million, both below the figures posted a year earlier.
  • This marks a rare year-over-year decline in revenue and net income for Evolution, despite ongoing efforts to expand in regulated markets and enhance product offerings.
  • Now, we'll examine how this decreased revenue and net income may affect Evolution's long-term investment outlook and risk profile.

Trump's oil boom is here - pipelines are primed to profit. Discover the 22 US stocks riding the wave.

Advertisement

Evolution Investment Narrative Recap

Owning Evolution stock means believing in the company’s ability to expand in regulated markets, drive innovation in live casino products and maintain profitable growth despite regulatory changes and rising costs. The latest quarterly decline in revenue and net income is a setback, especially as it coincides with near-term regulatory pressures in Europe, but does not appear to materially affect the most important catalyst: the opening of new regulated markets. The biggest immediate risk remains the impact of stricter European regulation, which could continue to pressure margins and revenue consistency.

Among recent developments, Evolution’s exclusive multi-year agreement with Hasbro to launch branded online live casino and slot games stands out. This partnership is relevant because it supports Evolution’s ongoing product innovation and differentiation, aligning with the key catalyst of capturing growth as more regulated markets allow sophisticated and branded offerings. It serves as a counterbalance to short-term regulatory challenges by enhancing Evolution’s appeal in markets where branded content commands premium pricing and higher engagement.

By contrast, investors should be aware that tightening European regulations may ...

Read the full narrative on Evolution (it's free!)

Evolution’s outlook anticipates €2.7 billion in revenue and €1.3 billion in earnings by 2028. This scenario assumes a 5.8% annual revenue growth rate and an earnings increase of €0.1 billion from current earnings of €1.2 billion.

Uncover how Evolution's forecasts yield a SEK817.27 fair value, a 29% upside to its current price.

Exploring Other Perspectives

OM:EVO Community Fair Values as at Nov 2025
OM:EVO Community Fair Values as at Nov 2025

Thirty-four fair value estimates from the Simply Wall St Community range from SEK747.99 to SEK1,955.97 per share, reflecting diverse opinions and significant variance. While many focus on upside potential, current regulatory headwinds in Europe may limit revenue growth and bring increased earnings volatility, reminding you that market consensus is far from uniform.

Explore 34 other fair value estimates on Evolution - why the stock might be worth over 3x more than the current price!

Build Your Own Evolution Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

  • A great starting point for your Evolution research is our analysis highlighting 4 key rewards that could impact your investment decision.
  • Our free Evolution research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Evolution's overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

Our top stock finds are flying under the radar-for now. Get in early:

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Evolution might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About OM:EVO

Evolution

Develops, produces, markets, and licenses live casino and slots solutions to gaming operators in Europe, Asia, North America, Latin America, and internationally.

Flawless balance sheet and undervalued.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1155.3% undervalued
50 users have followed this narrative
2 users have commented on this narrative
9 users have liked this narrative
BL
BlackGoat
IREN logo
BlackGoat on IREN ·

IREN's Bold Moves in Sustainable Bitcoin Mining & AI Data Centers

Fair Value:US$71.4849.2% undervalued
204 users have followed this narrative
6 users have commented on this narrative
32 users have liked this narrative
HE
HedgeY
ARM logo
HedgeY on Arm Holdings ·

The Architecture Layer of AI Computing - But Priced Like the Future Already Arrived?

Fair Value:US$43038.1% undervalued
9 users have followed this narrative
1 users have commented on this narrative
3 users have liked this narrative
HI
Hidden_Rock_Capital
FISV logo
Hidden_Rock_Capital on Fiserv ·

Temporary "perfect storm" leads to opportunity to buy financial services leader for less than 5x long-term earnings

Fair Value:US$119.9956.4% undervalued
13 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative

Updated Narratives

CL
Clive_Thompson
6831 logo
Clive_Thompson on Green Tea Group ·

One of China's Fastest-Growing Restaurant Chains Trades on Just 7x Earnings and an 8% Dividend

Fair Value:HK$8.728.9% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AZ
PRG logo
aziz_22khi on PRG Holdings Berhad ·

WHERE DID THE SIX MILLION SHARES GO? THE PRG OWNERSHIP TRAIL INVESTORS CANNOT IGNORE

Fair Value:RM 0.4477.3% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BR
Brunhilde_Wagner
CPRT logo
Brunhilde_Wagner on Copart ·

Compounder to Cash Generator in Real Time

Fair Value:US$2710.3% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.917.3% undervalued
86 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28029.8% undervalued
195 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.7% undervalued
72 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0
AN
CSMG3 logo
andre_k1tsg on Companhia de Saneamento de Minas Gerais ·

Gostei

0
|
0